Tough decisions must be made about further treatment after breast cancer. In today's Academic Minute, the University of Massachusetts Amherst's Jeff Blaustein discusses the pros and cons of estrogen blockers and what women should know about this avenue of treatment. Blaustein is a professor in the department of psychological and brain sciences at UMass Amherst. A transcript of this podcast can be found here.
What Others Are Reading